Skip to content
Home/Monique Adams, Ph.D.
leadership/monique-adams.png

Monique Adams, Ph.D.

Director, JCI

Monique Adams is the Director of Janssen Clinical Innovation, where she leads the strategy development and implementation plans for innovation initiatives within patient centrality, non-conventional trial methods, and patient data for research areas. She also manages the innovation project leads.

Monique has a broad understanding of clinical development, gained through years of experience across Medical Affairs and Global Clinical Operations in different market environments. She comes to Janssen from Bristol-Myers Squibb (BMS) where she most recently developed the Clinical Trial Transparency capability which included building a team responsible for disclosure activities globally and the development of a registration & results reporting platform. She has provided thought leadership in this domain through multiple roles within TransCelerate, a biopharma consortium. In addition to her leadership over Clinical Trial Transparency, Monique had oversight for the non-clinical academic collaborations. She has a BS in biology, a MS in physiology, and earned her Ph.D. in pharmacology from University of Washington.